Amgen Inc. DL-Notes 2023(23/30)

BID
-
ASK
-
0 Nom.0 Nom.
07/27, 22:05:00 PM

SPREAD (ACT/ REL)- / -
CHANGE COMPARED WITH PREVIOUS DAY (PRICE)0.05%
TODAY'S HIGH (PRICE)101.11
TODAY'S LOW (PRICE)101.019
Week 52 High (Price)104.55
Week 52 Low (Price)100.86

Yield Curves

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

5.00

Yield spread Bundesanleihe

2.1588

Tradable for private investors

Minimum amount tradeable unit

2,000.00

Maturity

02/03/2030

Interest Rate

5.25 %

Currency

US Dollar

Facts & figures

Price data


TRADE PLATFORM
LAST PRICE / YIELD	101.024 G / 5.00	0 Units
PRICE DETERMINATION TIME	07/27/2026 / 09:45:12 PM
DAILY VOLUME (NOMINAL)	0
YIELD SPREAD	2.1588
FIXINGPRICE	-
DAILY HIGH / LOW	101.11	101.019
PREV. DAY'S PRICE	100.978	(07/24)
CHANGE DAY BEFORE	+0.05	0.05 %
52 WEEK HIGH / LOW	104.55 (03/02)	100.86 (07/23)

More Price Information

Master Data


WKN	A3LEH5
ISIN	US031162DQ06
SYMBOL	-
EXCHANGE SEGMENT	Freiverkehr
TYPE OF FINANCIAL INSTRUMENT	Corporate Bond
SUB-TYPE	Health Care
ISSUER	Amgen Inc.
S&P RATING	Please log in to view this field
(TRADING) SEGMENT / TICKS	-/ -
TRADING HOURS	07:30:00 AM - 10:00:00 PM
INTEREST RATE	5.25 %
INTEREST RUN FROM	02/03/2023
NEXT INTEREST PAYMENT	02/09/2026
UNIT INTEREST FROM NOMINAL AMMOUNT	2.144 %


TRADING CURRENCY / NOTATION	US Dollar/ Percent
NOMINAL CURRENCY	US Dollar
SETTLEMENT CURRENCY	Euro
QUOTATION	Continuous trading
ISSUING VOLUME	2.75 Bil.
MINIMUM AMOUNT TRADEABLE UNIT	2,000.00
SMALLEST TRADEABLE UNIT	1,000.00
MATURITY	02/03/2030
MARKET MAKER	-
STEP UP/ DOWN WHEN RATING CHANGES	No
STEP UP FIXED AT ISSUE	No
STEP DOWN FIXED AT ISSUE	No
BOND CALLABLE BY THE ISSUER	Yes
BOND IS SUBORDINATED	No

Description

Local currency bond: USD. Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.